Sentence examples for data from the exploratory from inspiring English sources

The qualitative data from the exploratory phase led to the intervention being adapted for the main trial.

Preliminary data from the exploratory efficacy analysis show that patients with HER2-positive aGC treated with the combination of pertuzumab, trastuzumab, capecitabine and cisplatin achieved high rates of partial response (86% in Arm A and 55% in Arm B) or stable disease (14% in Arm A and 27% in Arm B) at the end of cycle 6.

The data from this exploratory study are presented in an effort to better understand the process of career-interest formation and how this process differs by social identity, providing an emerging framework that can be tested in future work and against which others' experiences can be examined and compared.

However, it was difficult to see any further pattern to the data from this exploratory analysis.

Taken together, the data from this exploratory analysis indicate that patients with baseline Hb < 10 g/dL and ≥10 g/dL may benefit from ESA therapy.

The data from this exploratory mutational analysis performed in this relatively small number of subjects with a relatively high number of censored data indicate that the presence of a KRAS mutation does not preclude regorafenib activity.

In order to predict CMC (coalbed methane content) accurately in advance during exploration stage with limited data in Pannan coalfield, Southwest China, the prediction models of CMC (coalbed methane content) were established using quantification theory on the foundation of limited data obtained from the exploratory bores.

The present analysis reports on the pooled safety data from the two exploratory phase 2 studies 12, 13 and the two PREEMPT trials 6– 8, 14.

Data from the present exploratory analysis indicate that EVE + EXE may be an effective and tolerable first-line therapy for advanced breast cancer after (neo)adjuvant NSAI treatment.

Preliminary analyses with the current sample showed a similar pattern of results to those obtained elsewhere (data from these exploratory analyses are not presented in the present manuscript but are available from the corresponding author upon request).

Data from this exploratory study indicate that sunitinib given in combination with paclitaxel has an acceptable safety profile in patients with advanced breast cancer.